Mentions (24h)
Mentions (7d)
Sentiment (avg / median)
Sentiment Mix
Coverage Z-Score (24h vs 90d)
Top Sources (7d)
Co-Topics (7d)
Mentions by Hour (Last 24h)
Cough Syrups Linked To Child Deaths Not Shipped To U.S., FDA Makes Clear
The U.S. Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children’s deaths in India had not been shipped to the United States. The World Health Organization has said India has a “regulatory gap…
Daily Wire · 2025-10-10 19:47:15
Trump Announces U.S. Drug Pricing Deal With AstraZeneca
President Donald Trump unveiled a deal with U.K.-based drugmaker AstraZeneca on Friday under which the company will sell some medicines at a discount to the government’s Medicaid health plan in exchange for tariff relief, similar to a…
Daily Wire · 2025-10-10 18:17:16
How Trump’s Latest Tariffs May Affect Your Medicines
The president said he would impose a tariff of 100 percent on certain brand-name drugs. Here’s what we know so far.…
New York Times Business · 2025-09-26 20:25:31
Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs
European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trump’s latest tariff barrage.…
New York Times Business · 2025-09-26 13:57:22Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
The Eli Lilly plant is the first of four planned U.S. manufacturing sites, which will begin making medicines within five years. …
CNBC Business · 2025-09-16 14:30:01Stocks making the biggest moves midday: Delta Air Lines, Revolution Medicines, Centene and more
These are the stocks posting the largest moves midday.…
CNBC Finance · 2025-09-11 16:22:22
Trump Weighs Crackdown on Medicines From China
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.…
New York Times Business · 2025-09-10 09:00:37Precigen Secures $125 Mln Credit Facility From Pharmakon To Advance PAPZIMEOS Commercialization
(RTTNews) - Precigen, Inc. (PGEN), a biopharmaceutical company focused on precision medicines, has entered into a credit facility agreement with funds managed by Pharmakon Advisors, LP. …
NASDAQ Markets · 2025-09-03 22:35:25
J&J earmarks $2B for Fujifilm’s North Carolina facility
The 10-year deal will expand the biopharma giant’s capacity to better meet U.S. demand for advanced medicines and create 120 jobs for the Raleigh area.…
Construction Dive · 2025-08-27 14:09:00
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Them
President Trump’s planned pharmaceutical tariffs threaten to hit many of the most common and well-known drugs that Americans take.…
New York Times Business · 2025-08-23 09:00:48
